caselaw.findlaw.com/us-3rd-circuit/1313639.html

ASTRAZENECA PHARMACEUTICALS LP. ... Alvin EMORY, Appellant v. ... of the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq. Moving for summary judgment, AstraZeneca urged that Emory's substantive ... In all, Emory bid unsuccessfully for approximately ten internal promotions over a 12-year period.

caselaw.findlaw.com/us-3rd-circuit/1681038.html

Case opinion for US 3rd Circuit UNITED STATES SCHUMANN v. ... ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers Squibb ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District Court's .... At all relevant times, BMS participated in Medicaid's Drug Rebate Program with ...

law.justia.com/cases/federal/appellate-courts/ca1/15-2232/15-2232-2017-05-02.html

May 8, 2017 ... Plaintiff appealed the district court's grant of summary judgment in favor of her former employer, AstraZeneca Pharmaceutical LP, on Plaintiff's ...

www.ftc.gov/system/files/documents/amicus_briefs/mylan-pharmaceuticals-inc.v.warner-chilcott-plc-et-al./151001mylanamicusbrief.pdf

Sep 30, 2015 ... BRADLEY S. ALBERT ..... Astrazeneca Pharms., L.P., .... Murray L. Aitken et al., The Regulation of Prescription Drug Competition and.

www.sunsteinlaw.com/media/2012_03_IP_Update_IAB.pdf

Feb 9, 2012 ... ... were on the brief for defendants-appellees Cobalt Pharmaceuticals Inc., et al. ... AstraZeneca Pharms. LP v. Apotex Corp.,. Nos. 10-338 to -346 and 10-584, 2010 U.S. Dist. LEXIS. 132727 .... Bradley v. Chiron. Corp., 136 ...

www.courthousenews.com/wp-content/uploads/2017/10/Anti-terrorism-Act-Lawsuit.pdf

Oct 17, 2017 ... Defendant AstraZeneca Pharmaceuticals LP is a wholly owned .... 2 Paul A. Volcker et al., Manipulation Of The Oil-for-Food ... 33-41, SEC v. ...... 286 Ed Bradley, Hezbollah: “A-Team of Terrorists”, CBS News (Apr. 18, 2003),.

www.nhd.uscourts.gov/judgements-civil-cases-2015

Federal National Mortgage Association et al ... Joseph et al v. ... NH Department of Corrections, Commissioner et al .... et al v. Astrazeneca Pharmaceuticals LP

www.ncbi.nlm.nih.gov/pmc/articles/PMC4505202

Mean Vz was highest in subjects with the earliest gestational age (<32 weeks): 0.564 ... B. Casteñeda-Ruiz, R. Redman, and J. Bradley, poster presented at the 44th American ... completed doripenem single-dose pharmacokinetics and safety study (Cirillo et al., poster). ..... AstraZeneca Pharmaceuticals LP, Wilmington, DE.

theoncologist.alphamedpress.org/content/21/8/954.full

Jun 2, 2016 ... This agent (Lynparza; AstraZeneca Pharmaceuticals, LP, Wilmington, ... 0.14– 0.74]; p = .008) than the BRCA mutation group (PFS, 19.4 vs. .... Therefore, all patients taking olaparib should be screened for fatigue .... Manuscript writing: Kathleen N. Moore, Bradley J. Monk ... Torre LA, Brah F, Siegel R et al.